Back to Search
Start Over
Metabolomics, Microbiota, and In Vivo and In Vitro Biomarkers in Type 2 Severe Asthma: A Perspective Review
- Source :
- Metabolites, Vol 11, Iss 647, p 647 (2021), Metabolites
- Publication Year :
- 2021
- Publisher :
- MDPI AG, 2021.
-
Abstract
- Precision medicine refers to the tailoring of therapeutic strategies to the individual characteristics of each patient; thus, it could be a new approach for the management of severe asthma that considers individual variability in genes, environmental exposure, and lifestyle. Precision medicine would also assist physicians in choosing the right treatment, the best timing of administration, consequently trying to maximize drug efficacy, and, possibly, reducing adverse events. Metabolomics is the systematic study of low molecular weight (bio)chemicals in a given biological system and offers a powerful approach to biomarker discovery and elucidating disease mechanisms. In this point of view, metabolomics could play a key role in targeting precision medicine.
- Subjects :
- business.industry
Endocrinology, Diabetes and Metabolism
Environmental exposure
Review
asthma
Bioinformatics
Precision medicine
medicine.disease
Biochemistry
metabolomics
Microbiology
QR1-502
Efficacy
Metabolomics
In vivo
microbiota
Medicine
Biomarker discovery
business
Adverse effect
Molecular Biology
Asthma
Subjects
Details
- Language :
- English
- ISSN :
- 22181989
- Volume :
- 11
- Issue :
- 647
- Database :
- OpenAIRE
- Journal :
- Metabolites
- Accession number :
- edsair.doi.dedup.....dc0a5ec783b9f670843b9deaded931ff